
    
      The study has now completed see Primary publication:

      Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive
      multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.

      Chataway J, Schuerer N, Alsanousi A, Chan D, MacManus D, Hunter K, Anderson V, Bangham CR,
      Clegg S, Nielsen C, Fox NC, Wilkie D, Nicholas JM, Calder VL, Greenwood J, Frost C, Nicholas
      R.

      Lancet. 2014 Jun 28;383(9936):2213-21. doi: 10.1016/S0140-6736(13)62242-4.
    
  